New Hope is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Metagenics Enrolls Over 700 Patients in Nationwide Health-Promotion Challenge


SAN CLEMENTE, CA—September 24, 2003—As part of its ongoing mission to help improve health through nutrition, Metagenics, Inc. recently announced the winners of its first annual UltraMeal Challenge—a nationwide health challenge to promote healthy body composition (lean to fat mass). Altered body composition is when the ratio of fat tissue to lean (e.g., muscle) tissue is elevated resulting in excess body fat. Over 65% of American adults have an altered body composition, which classifies them as unhealthy and puts them at risk for serious health concerns, such as cardiovascular disease and diabetes. In fact, half of all Americans with altered body composition have elevated cholesterol and about 70% have type 2 diabetes. Available exclusively through physicians and other licensed healthcare practitioners, UltraMeal is a line of medical food products designed to nutritionally support conditions associated with altered body composition including dyslipidemia, hypertension, estrogen imbalance, and metabolic syndrome.

More than 700 patients nationwide signed up for the UltraMeal Challenge—the first in UltraMeal’s 13-year history of clinical use worldwide. Patients with altered body composition were asked to follow the UltraMeal Body Composition Program for 12 weeks as directed by their healthcare provider. The UltraMeal Body Composition Program, which also includes a dietary plan and simple exercise regimen, has been clinically tested and shown to help reduce body fat and promote retention of lean body tissue.

To document each patient’s progress, healthcare providers measured body composition by using approved bioelectrical impedance analysis (BIA) equipment, which provides an accurate, noninvasive measure of both fat and lean tissue compartments. Eight total winners (four male and four female) were selected based on body composition improvement and a completed entry statement of their 12-week experience. Along with the titles of Mr. and Ms. UltraMeal, the grand prize winners were awarded $5,000 and a one-year maintenance supply of UltraMeal.

“This can’t be me who has such unbelievable energy. But wait, yes it is,” said Joy L., the newly crowned Ms. UltraMeal. “I owe many thanks to UltraMeal.” A resident of West Dundee, IL, Joy decreased her body fat percentage by 9%.

Mr. UltraMeal, David W. of Middlefield, CT, lost an astounding 15.4% body fat in just 12 weeks. “My blood pressure has dropped significantly, and my energy level has elevated. The program was easy, fun, and inexpensive,” David explained. Dr. Stephen Fowler, David’s physician, elaborated further, “The best part was watching David’s energy and self-esteem grow throughout the program. What a change in personality!”

“The goal of this health challenge was to increase patient’s awareness of altered body composition and its relationship to serious health concerns,” said Dr. Jeffrey Bland, President and Chief Science Officer of Metagenics, Inc. “We were very pleased to hear of the health improvements these patients experienced as they incorporated UltraMeal in a regimen of positive lifestyle changes.” Dr. Bland was instrumental in the development of UltraMeal, which is now available in eight soy-based shake formulas and the ready-to-eat UltraMeal® Bar. Metagenics looks forward to the next UltraMeal Challenge that will commence in January 2004.

About Metagenics
Metagenics, a privately held company, was founded in 1983 with the mission to help patients achieve their genetic potential through targeted nutrition. The company is headquartered in San Clemente, CA, with its world-class Functional Medicine Research Center (FMRC) and manufacturing facility located in Gig Harbor, WA. MetaProteomics™, Metagenics’ vanguard research center located in Ithaca, NY, is dedicated to researching and evaluating the effects of natural ingredients on genetic expression and protein activity. With a talent base of over 350 employees worldwide, including a team of nearly 40 highly trained scientists and clinicians, Metagenics is helping to shape the future of the nutraceutical industry. The company is GMP (Good Manufacturing Practices) certified by the NNFA, holds multiple proprietary formula patents, and produces over 400 all-natural, research-based products to optimize health. Committed to innovative product development, research, and continuing practitioner education, Metagenics is the premier formulator and manufacturer of premium-quality nutritional supplements and medical foods sold to healthcare practitioners worldwide. For more information about Metagenics, please visit the company’s Web site at


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.